• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

Wee1激酶抑制剂AZD1775通过诱导复制应激使肝细胞癌对放疗敏感,与TP53突变状态无关。

Wee1 Kinase Inhibitor AZD1775 Radiosensitizes Hepatocellular Carcinoma Regardless of TP53 Mutational Status Through Induction of Replication Stress.

作者信息

Cuneo Kyle C, Morgan Meredith A, Davis Mary A, Parcels Leslie A, Parcels Joshua, Karnak David, Ryan Caila, Liu Na, Maybaum Jonathan, Lawrence Theodore S

机构信息

Department of Radiation Oncology, University of Michigan, Ann Arbor, Michigan.

Department of Radiation Oncology, University of Michigan, Ann Arbor, Michigan.

出版信息

Int J Radiat Oncol Biol Phys. 2016 Jun 1;95(2):782-90. doi: 10.1016/j.ijrobp.2016.01.028. Epub 2016 Jan 22.

DOI:10.1016/j.ijrobp.2016.01.028
PMID:26975930
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC6644066/
Abstract

PURPOSE

Wee1 kinase inhibitors are effective radiosensitizers in cells lacking a G1 checkpoint. In this study we examined the potential effect of Wee1 kinase inhibition on inducing replication stress in hepatocellular carcinoma (HCC).

METHODS AND MATERIALS

Five independent datasets from the Oncomine database comparing gene expression in HCC compared to normal tissue were combined and specific markers associated with Wee1 sensitivity were analyzed. We then performed a series of in vitro experiments to study the effect of Wee1 inhibition on irradiated HCC cell lines with varying p53 mutational status. Clonogenic survival assays and flow cytometry using anti-γH2AX and phospho-histone H3 antibodies with propidium iodide were performed to study the effect of AZD1775 on survival, cell cycle, and DNA repair. Additionally, nucleoside enriched medium was used to examine the effect of altering nucleotide pools on Wee1 targeted radiation sensitization.

RESULTS

Our analysis of the Oncomine database found high levels of CDK1 and other cell cycle regulators indicative of Wee1 sensitivity in HCC. In our in vitro experiments, treatment with AZD1775 radiosensitized and chemosensitized Hep3B, Huh7, and HepG2 cell lines and was associated with delayed resolution of γH2AX foci and the induction of pan-nuclear γH2AX staining. Wee1 inhibition attenuated radiation-induced G2 arrest in the Hep3B (TP53 null) and Huh7 (TP53 mutant) cell lines but not in the TP53 wild-type cell line HepG2. Supplementation with nucleosides reversed the radiation-sensitizing effect of AZD1775 and reduced the amount of cells with pan-nuclear γH2AX staining after radiation.

CONCLUSIONS

Radiation sensitization with Wee1 inhibition occurs in cells regardless of their p53 mutational status. In this study we show for the first time that replication stress via the overconsumption of nucleotides plays an important role in AZD1775-induced radiation sensitization.

摘要

目的

Wee1激酶抑制剂在缺乏G1期检查点的细胞中是有效的放射增敏剂。在本研究中,我们检测了抑制Wee1激酶对诱导肝细胞癌(HCC)复制应激的潜在影响。

方法和材料

合并来自Oncomine数据库的五个独立数据集,比较HCC与正常组织中的基因表达,并分析与Wee1敏感性相关的特定标志物。然后,我们进行了一系列体外实验,以研究抑制Wee1对不同p53突变状态的受辐照HCC细胞系的影响。使用抗γH2AX和磷酸化组蛋白H3抗体与碘化丙啶进行克隆形成存活分析和流式细胞术,以研究AZD1775对存活、细胞周期和DNA修复的影响。此外,使用富含核苷的培养基来检测改变核苷酸库对Wee1靶向放射增敏的影响。

结果

我们对Oncomine数据库的分析发现,HCC中存在高水平的CDK1和其他细胞周期调节因子,表明其对Wee1敏感。在我们的体外实验中,用AZD1775处理使Hep3B、Huh7和HepG2细胞系产生放射增敏和化学增敏作用,并与γH2AX灶延迟消退和全核γH2AX染色诱导相关。抑制Wee1减弱了辐射诱导的Hep3B(TP53缺失)和Huh7(TP53突变)细胞系中的G2期阻滞,但在TP53野生型细胞系HepG2中未减弱。补充核苷可逆转AZD1775的放射增敏作用,并减少辐射后全核γH2AX染色的细胞数量。

结论

无论细胞的p53突变状态如何,抑制Wee1均会产生放射增敏作用。在本研究中,我们首次表明,核苷酸过度消耗引起的复制应激在AZD1775诱导的放射增敏中起重要作用。

相似文献

1
Wee1 Kinase Inhibitor AZD1775 Radiosensitizes Hepatocellular Carcinoma Regardless of TP53 Mutational Status Through Induction of Replication Stress.Wee1激酶抑制剂AZD1775通过诱导复制应激使肝细胞癌对放疗敏感,与TP53突变状态无关。
Int J Radiat Oncol Biol Phys. 2016 Jun 1;95(2):782-90. doi: 10.1016/j.ijrobp.2016.01.028. Epub 2016 Jan 22.
2
Wee1 Kinase Inhibitor AZD1775 Effectively Sensitizes Esophageal Cancer to Radiotherapy.Wee1 激酶抑制剂 AZD1775 有效增强食管癌对放疗的敏感性。
Clin Cancer Res. 2020 Jul 15;26(14):3740-3750. doi: 10.1158/1078-0432.CCR-19-3373. Epub 2020 Mar 27.
3
The contribution of DNA replication stress marked by high-intensity, pan-nuclear γH2AX staining to chemosensitization by CHK1 and WEE1 inhibitors.由高强度、全核 γH2AX 染色标记的 DNA 复制应激对 CHK1 和 WEE1 抑制剂增敏作用的贡献。
Cell Cycle. 2018;17(9):1076-1086. doi: 10.1080/15384101.2018.1475827. Epub 2018 Jul 18.
4
Sensitization of Pancreatic Cancers to Gemcitabine Chemoradiation by WEE1 Kinase Inhibition Depends on Homologous Recombination Repair.通过抑制WEE1激酶使胰腺癌对吉西他滨放化疗敏感取决于同源重组修复。
Neoplasia. 2015 Oct;17(10):757-66. doi: 10.1016/j.neo.2015.09.006.
5
Augmented antitumor activity by olaparib plus AZD1775 in gastric cancer through disrupting DNA damage repair pathways and DNA damage checkpoint.奥拉帕利联合 AZD1775 通过破坏 DNA 损伤修复途径和 DNA 损伤检查点增强胃癌的抗肿瘤活性。
J Exp Clin Cancer Res. 2018 Jun 28;37(1):129. doi: 10.1186/s13046-018-0790-7.
6
MK-1775, a novel Wee1 kinase inhibitor, radiosensitizes p53-defective human tumor cells.MK-1775,一种新型的 Wee1 激酶抑制剂,可增敏 p53 缺陷型人类肿瘤细胞的放射敏感性。
Clin Cancer Res. 2011 Sep 1;17(17):5638-48. doi: 10.1158/1078-0432.CCR-11-0650. Epub 2011 Jul 28.
7
G2-checkpoint targeting and radiosensitization of HPV/p16-positive HNSCC cells through the inhibition of Chk1 and Wee1.通过抑制Chk1和Wee1对HPV/p16阳性头颈部鳞状细胞癌(HNSCC)细胞进行G2检查点靶向和放射增敏作用。
Radiother Oncol. 2017 Feb;122(2):260-266. doi: 10.1016/j.radonc.2016.11.017. Epub 2016 Dec 9.
8
WEE1 Kinase Inhibitor AZD1775 Has Preclinical Efficacy in LKB1-Deficient Non-Small Cell Lung Cancer.WEE1 激酶抑制剂 AZD1775 在 LKB1 缺陷型非小细胞肺癌中有临床前疗效。
Cancer Res. 2017 Sep 1;77(17):4663-4672. doi: 10.1158/0008-5472.CAN-16-3565. Epub 2017 Jun 26.
9
Increased activity of both CDK1 and CDK2 is necessary for the combinatorial activity of WEE1 inhibition and cytarabine.CDK1和CDK2活性的增加对于WEE1抑制和阿糖胞苷的联合活性是必需的。
Leuk Res. 2018 Jan;64:30-33. doi: 10.1016/j.leukres.2017.11.004. Epub 2017 Nov 11.
10
Replication Stress Leading to Apoptosis within the S-phase Contributes to Synergism between Vorinostat and AZD1775 in HNSCC Harboring High-Risk Mutation.复制压力导致 S 期细胞凋亡,这有助于高危突变的头颈部鳞状细胞癌中伏立诺他和 AZD1775 的协同作用。
Clin Cancer Res. 2017 Nov 1;23(21):6541-6554. doi: 10.1158/1078-0432.CCR-17-0947. Epub 2017 Aug 8.

引用本文的文献

1
Synergistic antitumor effect of MK-1775 and CUDC-907 against prostate cancer.MK-1775与CUDC-907联合对前列腺癌的协同抗肿瘤作用
Invest New Drugs. 2025 Feb;43(1):157-166. doi: 10.1007/s10637-024-01490-8. Epub 2025 Jan 27.
2
The Potential for Targeting G/M Cell Cycle Checkpoint Kinases in Enhancing the Efficacy of Radiotherapy.靶向G/M期细胞周期检查点激酶增强放疗疗效的潜力
Cancers (Basel). 2024 Aug 29;16(17):3016. doi: 10.3390/cancers16173016.
3
Targeting WEE1 Kinase in Gynecological Malignancies.靶向妇科恶性肿瘤中的 WEE1 激酶。

本文引用的文献

1
Advances in targeted therapies for hepatocellular carcinoma in the genomic era.基因组时代肝细胞癌的靶向治疗进展。
Nat Rev Clin Oncol. 2015 Jul;12(7):408-24. doi: 10.1038/nrclinonc.2015.103. Epub 2015 Jun 9.
2
Replication stress and cancer.复制压力与癌症。
Nat Rev Cancer. 2015 May;15(5):276-89. doi: 10.1038/nrc3916.
3
Combined inhibition of Wee1 and PARP1/2 for radiosensitization in pancreatic cancer.联合抑制Wee1和PARP1/2用于胰腺癌的放射增敏作用。
Drug Des Devel Ther. 2024 Jun 20;18:2449-2460. doi: 10.2147/DDDT.S462056. eCollection 2024.
4
Targeting WEE1 kinase as a p53-independent therapeutic strategy in high-risk and relapsed acute lymphoblastic leukemia.将WEE1激酶作为高危和复发急性淋巴细胞白血病中一种不依赖p53的治疗策略。
Cancer Cell Int. 2023 Sep 15;23(1):202. doi: 10.1186/s12935-023-03057-8.
5
Impaired DNA double-strand break repair and effective radiosensitization of HPV-negative HNSCC cell lines through combined inhibition of PARP and Wee1.通过联合抑制PARP和Wee1来损害DNA双链断裂修复并使HPV阴性头颈部鳞状细胞癌细胞系产生有效的放射增敏作用。
Clin Transl Radiat Oncol. 2023 Apr 20;41:100630. doi: 10.1016/j.ctro.2023.100630. eCollection 2023 Jul.
6
Bosutinib high density lipoprotein nanoformulation has potent tumour radiosensitisation effects.博舒替尼高密度脂蛋白纳米制剂具有很强的肿瘤放射增敏作用。
J Nanobiotechnology. 2023 Mar 21;21(1):102. doi: 10.1186/s12951-023-01848-9.
7
G2 checkpoint targeting via Wee1 inhibition radiosensitizes EGFRvIII-positive glioblastoma cells.通过抑制 Wee1 来靶向 G2 检查点可增敏 EGFRvIII 阳性脑胶质瘤细胞的放射敏感性。
Radiat Oncol. 2023 Jan 29;18(1):19. doi: 10.1186/s13014-023-02210-x.
8
A living biobank of matched pairs of patient-derived xenografts and organoids for cancer pharmacology.用于癌症药理学的患者来源异种移植物和类器官匹配对的活体生物银行。
PLoS One. 2023 Jan 5;18(1):e0279821. doi: 10.1371/journal.pone.0279821. eCollection 2023.
9
Targeting replication stress in cancer therapy.针对癌症治疗中的复制应激。
Nat Rev Drug Discov. 2023 Jan;22(1):38-58. doi: 10.1038/s41573-022-00558-5. Epub 2022 Oct 6.
10
Replication Stress: A Review of Novel Targets to Enhance Radiosensitivity-From Bench to Clinic.复制应激:增强放射敏感性的新靶点综述——从实验台到临床
Front Oncol. 2022 Jul 8;12:838637. doi: 10.3389/fonc.2022.838637. eCollection 2022.
Clin Cancer Res. 2014 Oct 1;20(19):5085-96. doi: 10.1158/1078-0432.CCR-14-1038. Epub 2014 Aug 12.
4
Low dose rate radiosensitization of hepatocellular carcinoma in vitro and in patients.体外和患者中低剂量率放射增敏肝癌。
Transl Oncol. 2014 Aug;7(4):472-8. doi: 10.1016/j.tranon.2014.05.006. Epub 2014 Jun 21.
5
Improving the efficacy of chemoradiation with targeted agents.提高靶向药物联合放化疗的疗效。
Cancer Discov. 2014 Mar;4(3):280-91. doi: 10.1158/2159-8290.CD-13-0337. Epub 2014 Feb 18.
6
Phase II trial of palliative radiotherapy for hepatocellular carcinoma and liver metastases.肝癌和肝转移的姑息性放疗的 II 期临床试验。
J Clin Oncol. 2013 Nov 1;31(31):3980-6. doi: 10.1200/JCO.2013.49.9202. Epub 2013 Sep 23.
7
Preclinical evaluation of the WEE1 inhibitor MK-1775 as single-agent anticancer therapy.WEE1 抑制剂 MK-1775 的临床前评估作为单一抗癌疗法。
Mol Cancer Ther. 2013 Aug;12(8):1442-52. doi: 10.1158/1535-7163.MCT-13-0025. Epub 2013 May 22.
8
Sequential phase I and II trials of stereotactic body radiotherapy for locally advanced hepatocellular carcinoma.立体定向体部放疗治疗局部进展期肝细胞癌的序贯 I 期和 II 期临床试验。
J Clin Oncol. 2013 May 1;31(13):1631-9. doi: 10.1200/JCO.2012.44.1659. Epub 2013 Apr 1.
9
Global and regional mortality from 235 causes of death for 20 age groups in 1990 and 2010: a systematic analysis for the Global Burden of Disease Study 2010.1990年和2010年20个年龄组中235种死因的全球和区域死亡率:全球疾病负担研究2010的系统分析
Lancet. 2012 Dec 15;380(9859):2095-128. doi: 10.1016/S0140-6736(12)61728-0.
10
The CDK1 inhibitory kinase MYT1 in DNA damage checkpoint recovery.CDK1 抑制激酶 MYT1 在 DNA 损伤检查点恢复中的作用。
Oncogene. 2013 Oct;32(40):4778-88. doi: 10.1038/onc.2012.504. Epub 2012 Nov 12.